The temples, cheeks, and under-eye areas are particularly susceptible to this volume depletion
Two states, Louisiana and South Carolina, provided coverage for one weight-loss drug that is not a GLP-1, orlistat
doi: 10.1007/s001250100548 27 ObozaPOgarekNOlszanecka-GlinianowiczMKocelakP
The standard approach involves incubating the test compound with liver-derived metabolic systems (microsomes, S9, or hepatocytes) in the presence of NADPH and other cofactors, then quantifying the parent compound remaining at multiple time points using mass spectrometry
Drug clearance (Cl) is concerned with the rate at which a drug is removed from the body
Clinical working case definition, diagnostic and treatment protocols